TARPLIN, DOWNS & YOUNG, LLC

Lobbying for NOVOCURE INC. · Oncology company with novel therapy for solid tumors

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · Pennsylvania · House · Senate · $80,000.00 income · posted Oct 15, 2025

Lobbying activity 2

Medicare/Medicaid

Medicare coverage and reimbursement, national coverage determinations

Health Issues

FDA policies

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.